© 1999 American Heart Association, Inc.
Editorials |
Vascular Tissue Engineering
Designer Arteries
From the Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Mass, and Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Elazer R. Edelman, Division of Health Sciences and Technology, Massachusetts Institute of Technology, Room 16-343, 77 Massachusetts Ave, Cambridge, MA 02139. E-mail eedelman@mit.edu
Key Words: tissue engineering • vascular graft
 |
Introduction |
|---|
The fields of vascular biology and vascular medicine are so intertwined that advances in one predict, explain, or are required for progress in the other. Bypass grafting, which once served as a "bailout" procedure,1 2 is now performed more than 600 000 times annually in the United States. In major part, this increase can be attributed to a surge in understanding of the vascular response to injury. At the same time, the science of vascular biology has been primarily stimulated by the clinical imperative to combat complications that ensue from vascular interventions.3 Thus, when a novel vascular biological finding or cardiovascular medical/surgical technique is presented, we are required to ask the 2-fold question: what have we learned about the biology of the blood vessel, and how might this knowledge be used to enhance clinical perspective and treatment? The innovative method of engineering arterial conduits presented by Campbell et al4 in this issue of Circulation Research presents us with just such a challenge, and I will attempt to deal with the biological and clinical ramifications of this work.
|
Vascular Grafting |
|---|
Although routinely applied and ubiquitously used, vascular grafting is not without significant constraints and complications.3 Arterial conduits are in limited supply and restricted dimensions. Venous conduits are more abundant but lack vasomotor tone and are prone to thrombotic and hyperplastic occlusion and, less frequently, infection. Veins and arteries must be harvested from sites that leave wounds that can break down or become infected. Synthetic materials do not fare well in small-bore vascular beds and
This article has been cited by other articles:
 |
|
 |
|
  K. Torikai, H. Ichikawa, K. Hirakawa, G. Matsumiya, T. Kuratani, S. Iwai, A. Saito, N. Kawaguchi, N. Matsuura, and Y. Sawa A self-renewing, tissue-engineered vascular graft for arterial reconstruction J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 37 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hecker, K. Baar, R. G. Dennis, and K. N. Bitar Development of a three-dimensional physiological model of the internal anal sphincter bioengineered in vitro from isolated smooth muscle cells Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G188 - G196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Tepper, J. M. Capla, R. D. Galiano, D. J. Ceradini, M. J. Callaghan, M. E. Kleinman, and G. C. Gurtner Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells Blood, February 1, 2005; 105(3): 1068 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Walles, H. Gorler, C. Puschmann, and H. Mertsching Functional neointima characterization of vascular prostheses in human Ann. Thorac. Surg., March 1, 2004; 77(3): 864 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Fuchs, B. A. Nasseri, and J. P. Vacanti Tissue engineering: a 21st century solution to surgical reconstruction Ann. Thorac. Surg., August 1, 2001; 72(2): 577 - 591. [Abstract] [Full Text] [PDF]
|
|